Goldenrod Therapeutics
Develops novel brain-penetrant therapies targeting neuroinflammation and neuronal signaling pathways
Funding history
1 round- $6.5M
Develops novel brain-penetrant therapies targeting neuroinflammation and neuronal signaling pathways